영진약품(주) · KOSPI: 003520 · Pharmaceuticals and medicinal chemicals
| KRW | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Revenue | ₩234.9B | ₩252.0B | ₩254.3B |
| Operating income | ₩3.1B | ₩8.7B | ₩3.4B |
| Net income | −₩3.9B | ₩1.2B | −₩228M |
| Total assets | ₩226.6B | ₩234.3B | ₩262.4B |
| Total liabilities | ₩137.0B | ₩144.5B | ₩170.9B |
| Total equity | ₩89.6B | ₩89.8B | ₩91.5B |
| Share capital | ₩91.4B | ₩91.4B | ₩91.4B |
Separate statements · FY2025 operating margin 1.3% · liabilities to equity 187% · Annual report FY2025 (Korean original)
| Period | Auditor | Opinion |
|---|---|---|
| Term 64 (current) | 한울회계법인 | Unqualified |
| Term 63 (prior) | 한영회계법인 | Unqualified |
| Term 62 (two years prior) | 한영회계법인 | Unqualified |
No change history reported in the latest annual report.
| Date | Filing | Original |
|---|---|---|
| 2026-09-01 | Litigation filed | DART |
| 2026-08-28 | Large business group status disclosure | DART |
| 2026-08-14 | Half-year report (2026.06) | DART |
| 2026-08-13 | Payment terms to suppliers and dispute mediation body | DART |
| 2026-08-12 | Amended: Single sales / supply contract signed | DART |
| 2026-07-31 | Preliminary operating results (fair disclosure) | DART |
| 2026-07-24 | Amended: New facility investment | DART |
| 2026-06-01 | Large business group status disclosure | DART |
| 2026-05-28 | Corporate governance report | DART |
| 2026-05-15 | Quarterly report (2026.03) | DART |
| 2026-05-06 | Preliminary operating results (fair disclosure) | DART |
| 2026-03-20 | Independent director appointment / dismissal / resignation | DART |
| 2026-03-20 | Annual general meeting results | DART |
| 2026-03-12 | Annual report (2025.12) | DART |
| 2026-03-12 | Amended: Proxy solicitation reference document | DART |
| 2026-03-12 | Amended: Notice of shareholders meeting | DART |
| 2026-03-05 | Proxy solicitation reference document | DART |
| 2026-03-05 | Notice of shareholders meeting | DART |
| 2026-03-03 | Audit report submitted | DART |
| 2026-02-27 | Resolution to convene shareholders meeting | DART |
Showing the 20 most recent of 33 filings. The full brief lists all of them.
For business customers. EU companies: enter your VAT number at checkout and no VAT is charged (reverse charge).
Data generated 2026-09-16 from OpenDART.
This page summarizes public filings from DART, the official electronic disclosure system of Korea. It is not investment, credit or legal advice. Figures are shown in the currency the company reports in. Titles and labels are machine-translated and may contain errors — always check the linked original filing. Source: OpenDART, Financial Supervisory Service, Korea.